U.S. FDA approves Travere Therapeutics kidney disorder drug
Original source: https://www.investing.com/news/stock-market-news/us-fda-approves-travere-therapeutics-kidney-disorder-drug-3007455
Read More »U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke
Original source: https://www.investing.com/news/stock-market-news/us-says-pfizers-bivalent-covid-shot-may-be-linked-to-stroke-in-older-adults-2980360
Read More »U.S. FDA approves Mirati’s lung cancer drug
Original source: https://www.investing.com/news/stock-market-news/us-fda-approves-miratis-lung-cancer-drug-2962675
Read More »U.S. FDA commissioner Robert Califf tests positive for COVID
Original source: https://www.investing.com/news/stock-market-news/us-fda-commissioner-robert-califf-tests-positive-for-covid-2935319
Read More »U.S. FDA staff says Moderna COVID vaccine effective and safe for children
Original source: https://www.investing.com/news/stock-market-news/us-fda-staff-says-moderna-covid-vaccine-effective-and-safe-for-children-2835940
Read More »U.S. FDA considers approving a second COVID-19 booster shot -WSJ
Original source: https://www.investing.com/news/stock-market-news/us-fda-considers-approving-a-second-covid19-booster-shot-wsj-2767800
Read More »U.S. FDA panel narrowly backs Merck’s at-home COVID-19 pill
Original source: https://www.investing.com/news/stock-market-news/us-fda-panel-to-weigh-mercks-covid19-antiviral-drug-2694098
Read More »U.S. FDA declines to approve Revance’s frown-line treatment
Original source: https://www.investing.com/news/stock-market-news/us-fda-declines-to-approve-revances-frownline-treatment-2645689
Read More »